Trial Profile
Angiotensin Blocking Effect of Fimasartan on Hypertensive Cardiac Disease With Left Ventricular Hypertrophy Estimated by ECG: a Prospective, Multicenter, Observational Registry
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Jul 2017
Price :
$35
*
At a glance
- Drugs Fimasartan (Primary)
- Indications Hypertension; Left ventricular hypertrophy
- Focus Therapeutic Use
- 21 Jul 2017 New trial record